An internal standard for the quantification of tenofovir
Related Products
Unlabeled Version(s)
13874Tenofovir
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Tenofovir-d6

Item No. 21071

Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
P-[[1-[(6-amino-9H-purin-9-yl)methyl-d2]ethoxy-1,2,2,2-d4]methyl]-phosphonic acid
CAS Number
1020719-94-1
Synonyms
  • GS-1275-d6
  • GS-1278-d6
  • (R)-PMPA-d6
  • TDF-d6
Molecular Formula
C9H8D6N5O4P
Formula Weight
Purity
≥99% deuterated forms (d1-d6)
A solid
DMSO: SparinglyWater: Sparingly
SMILES
OP(COC(C([2H])([2H])[2H])([2H])C([2H])([2H])N1C=NC2=C(N)N=CN=C21)(O)=O
InChi Code
InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/i1D3,2D2,6D
InChi Key
SGOIRFVFHAKUTI-CUYPRXAISA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Tenofovir-d6 is intended for use as an internal standard for the quantification of tenofovir (Item No. 13874) by GC- or LC-MS. Tenofovir is an analog of adenosine monophosphate that has antiviral activity.1,2 It is converted by cellular enzymes to tenofovir diphosphate, an obligate chain terminator that inhibits the activity of HIV reverse transcriptase and hepatitis B virus polymerase.3,4 Tenofovir diphosphate is a weak inhibitor of mammalian DNA polymerases α and β and mitochondrial DNA polymerase γ.4 For in vivo and cell culture use, tenofovir is supplied as a water soluble prodrug in the form of tenofovir disoproxil (fumarate) (Item No. 16922), which increases the intracellular diphosphorylated compound >1,000-fold above the level attained with unmodified tenofovir.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Balzarini, J., Vahlenkamp, T., Egberink, H., et alAntiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newborn NMRI mice. Antimicrob. Agents Chemother. 41(3), 611-616 (1997).

    2. Balzarini, J., Holy, A., Jindrich, J., et alDifferential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: Potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine. Antimicrob. Agents Chemother. 37(2), 332-338 (1993).

    3. Van Gelder, J., Shafiee, M., De Clercq, E., et alSpecies-dependent and site-specific intestinal metabolism of ester prodrugs. Int. J. Pharm. 205(1-2), 93-100 (2000).

    4. Robbins, B.L., Srinivas, R.V., Kim, C., et alAnti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), bis(isopropyloxymethylcarbonyl)PMPA. Antimicrob. Agents Chemother. 42(3), 612-617 (1998).